Women on Mounjaro may miss signs of pancreatitis. Learn the symptoms, risks, and what UK health authorities are doing to ...

The medicines regulator is investigating after hundreds of people have reported problems with their pancreas linked to taking ...

Biocon cancels plans to market Novo Nordisk generics in China due to local competition, focusing on other markets.

Indian drugmaker Biocon has abandoned plans to market generic versions of Novo Nordisk’s hot-selling diabetes and weight-loss drugs in China due to local competition, a senior executive said.

A bill would allow Ohio state employees to purchase GLP-1s from manufacturers, then would require the Department of ...

Access is opening up for Kiwis to a weight loss drug described as a game changer. Wegovy, made by pharma-co Novo Nordisk, ...

A new bill could make the price of prescription drugs known for weight loss cheaper for the state to buy for its employees.

If you or your family and friends take some weight loss medications, you'll want to read this. Some users are reporting ...

Multiple pharmacists have told our newsroom it's set to hit New Zealand shelves next week. It's not funded by Pharmac, so users will have to pay and get a prescription for the weekly injectable which ...

The United Kingdom's health regulator is investigating weight loss jabs like Ozempic and Mounjaro after linking it to ...

Weight loss and diabetes jabs taken by more than a million people in the UK have been linked to a potential serious side effect, with some deaths, according to data from the UK medicines regulator.

The UK’s MHRA and Genomics England have launched a groundbreaking study to investigate whether genetics play a role in ...